1 Min Read
Dec 14 (Reuters) - Merck & Co Inc:
* MERCK & CO SAYS RECENTLY APPROVED PREVYMIS (LETERMOVIR) IS EXPECTED TO BE AVAILABLE IN CANADA BY END OF DECEMBER 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.